Alsadoun Lara, Ali Husnain, Mushtaq Muhammad Muaz, Mushtaq Maham, Burhanuddin Mohammad, Anwar Rahma, Liaqat Maryyam, Bokhari Syed Faqeer Hussain, Hasan Abdul Haseeb, Ahmed Fazeel
Trauma and Orthopaedics, Chelsea and Westminster Hospital, London, GBR.
Medicine and Surgery, King Edward Medical University, Lahore, PAK.
Cureus. 2024 Aug 26;16(8):e67844. doi: 10.7759/cureus.67844. eCollection 2024 Aug.
Diabetic retinopathy (DR) remains a leading cause of vision loss worldwide, with early detection critical for preventing irreversible damage. This review explores the current landscape and future directions of artificial intelligence (AI)-enhanced detection of DR from fundus images. Recent advances in deep learning and computer vision have enabled AI systems to analyze retinal images with expert-level accuracy, potentially transforming DR screening. Key developments include convolutional neural networks achieving high sensitivity and specificity in detecting referable DR, multi-task learning approaches that can simultaneously detect and grade DR severity, and lightweight models enabling deployment on mobile devices. While these AI systems show promise in improving the efficiency and accessibility of DR screening, several challenges remain. These include ensuring generalizability across diverse populations, standardizing image acquisition and quality, addressing the "black box" nature of complex models, and integrating AI seamlessly into clinical workflows. Future directions in the field encompass explainable AI to enhance transparency, federated learning to leverage decentralized datasets, and the integration of AI with electronic health records and other diagnostic modalities. There is also growing potential for AI to contribute to personalized treatment planning and predictive analytics for disease progression. As the technology continues to evolve, maintaining a focus on rigorous clinical validation, ethical considerations, and real-world implementation will be crucial for realizing the full potential of AI-enhanced DR detection in improving global eye health outcomes.
糖尿病视网膜病变(DR)仍是全球视力丧失的主要原因,早期检测对于预防不可逆转的损害至关重要。本综述探讨了基于眼底图像的人工智能(AI)增强型DR检测的现状和未来发展方向。深度学习和计算机视觉的最新进展使人工智能系统能够以专家级的准确性分析视网膜图像,这可能会改变DR筛查。关键进展包括卷积神经网络在检测可转诊的DR方面实现了高灵敏度和特异性,多任务学习方法可以同时检测DR并对其严重程度进行分级,以及能够在移动设备上部署的轻量级模型。虽然这些人工智能系统在提高DR筛查的效率和可及性方面显示出前景,但仍存在一些挑战。这些挑战包括确保在不同人群中的通用性、规范图像采集和质量、解决复杂模型的“黑箱”性质,以及将人工智能无缝集成到临床工作流程中。该领域的未来发展方向包括增强透明度的可解释人工智能、利用分散数据集的联邦学习,以及将人工智能与电子健康记录和其他诊断方式集成。人工智能在个性化治疗计划和疾病进展预测分析方面的贡献潜力也在不断增加。随着技术的不断发展,持续关注严格的临床验证、伦理考量和实际应用对于实现人工智能增强型DR检测在改善全球眼部健康结果方面的全部潜力至关重要。